Singapore's Research Powerhouse Reaches New Heights in Industry Collaboration

Singapore's Agency for Science, Technology and Research (A*STAR), the nation's flagship public sector research and development (R&D) organization, has marked a significant milestone by attracting over S$1.1 billion in industry investments through its innovative public-private partnerships (PPPs). This achievement underscores Singapore's strategic push to bridge academia, government, and industry, fostering cutting-edge innovations that drive economic growth and position the city-state as a global R&D hub.

Established in 2002, A*STAR plays a pivotal role in translating scientific discoveries into practical applications across sectors like manufacturing, healthcare, and advanced materials. By co-locating researchers from its institutes with industry experts in dedicated Corporate Laboratories (Corp Labs), A*STAR has created a symbiotic ecosystem where private sector funding complements government support. This model not only accelerates technology commercialization but also generates high-value jobs and spin-offs, contributing to Singapore's Research, Innovation, and Enterprise (RIE) 2025 Plan and beyond into RIE2030.

The Corporate Laboratories Scheme: Engine of Industry-Led R&D

At the heart of A*STAR's success is the Corporate Laboratories Scheme (CLS), launched to attract multinational corporations (MNCs) and local enterprises to invest in Singapore-based R&D. Under CLS, companies commit substantial funds—matched or leveraged by A*STAR and partners like the National Research Foundation (NRF)—to tackle real-world challenges. To date, this scheme has spurred dozens of labs, with cumulative industry investments surpassing S$1.1 billion since inception.

The process works step-by-step: First, A*STAR identifies strategic domains aligned with national priorities, such as semiconductors and sustainable manufacturing. Industry partners then propose projects, co-funding facilities, talent, and IP development. Researchers from A*STAR institutes, universities like Nanyang Technological University (NTU) and National University of Singapore (NUS), and company teams collaborate in shared spaces. Outcomes include patents, prototypes, and scalable technologies, with IP shared equitably to incentivize further investment.

This structure minimizes risk for industry while maximizing Singapore's talent pool—over 5,000 scientists and engineers at A*STAR alone—ensuring quick wins like the recent S$60 million ExxonMobil-NTU-A*STAR lab focused on low-carbon solutions.

Recent Milestones: Surging Investments in 2025-2026

2025 and 2026 have seen a surge in commitments, reflecting global confidence in Singapore's ecosystem amid geopolitical tensions. In October 2025, A*STAR partnered with local SMEs to launch three joint labs for advanced manufacturing, injecting over S$21 million in combined investments. Hyundai Motor Group, NTU, and A*STAR inaugurated Singapore's first automotive Corporate Lab in October 2025, targeting hydrogen energy and advanced systems. Meanwhile, the Committee of Supply 2026 announcement revealed a S$800 million government investment in a Semiconductor RIE Flagship, led by A*STAR and EDB, expected to draw matching industry funds and create thousands of jobs.

• S$60M ExxonMobil-NTU-A*STAR low-carbon lab (2024, ongoing impacts)
• S$30M SCG Cell Therapy-A*STAR iPSC joint labs
• S$21M SME advanced manufacturing labs
• S$6M SIA-A*STAR aircraft components labs (Feb 2026)

These initiatives build on historical successes, pushing total attracted investments well beyond the S$1.1 billion mark when including leveraged funding.

Semiconductors: A Flagship Focus for Future Growth

Semiconductors represent a crown jewel, with A*STAR's efforts aligning with global demand for AI chips and advanced nodes. The new RIE Flagship will expand R&D in packaging, photonics, and equipment, partnering with giants like GlobalFoundries and Zeiss. Already, A*STAR's S$12 million grant has boosted silicon photonics, vital for data centers. Industry heavyweights cite Singapore's IP protection, talent, and proximity to Asia markets as draws, with German firms like Infineon expanding labs here.

This sector alone could generate S$ billions in economic value, per EDB estimates, while training 10,000 specialists via university tie-ups.

Photo by Shaylyn on Unsplash

Synergies with Singapore's Universities: Bridging Academia and Industry

A*STAR's PPPs extend deeply into higher education, with joint labs hosted at NTU and NUS campuses. For instance, the Hyundai-NTU lab leverages NTU's engineering prowess, while ExxonMobil's involves NTU's energy researchers. These collaborations provide students and faculty access to industry projects, internships, and funding—key for Singapore's universities to stay competitive globally.

NUS and NTU rank among Asia's top 10, and A*STAR partnerships enhance their research output, with shared PhD programs and tech transfer. This creates a talent pipeline: fresh graduates enter Corp Labs, gaining hands-on experience before industry roles. In 2026, expect more such integrations under RIE2030, focusing on AI, quantum, and biotech.

Case Studies: Real-World Impacts from PPPs

Consider Rolls-Royce@NTU Corp Lab (Phase 2: S$88M), which advanced urban air mobility and sustainable aviation, yielding patents and spin-offs. Or Halliburton's NEX Lab (2026), targeting oilfield innovations with A*STAR's digital tech. In biotech, SCG's iPSC labs aim at scalable cell therapies, potentially revolutionizing treatments.

These yield tangible outcomes: 100+ patents annually, 500+ jobs created yearly, and S$ hundreds of millions in economic multipliers.

Stakeholder Perspectives: Voices from Industry and Academia

Industry leaders praise A*STAR's agility: "Singapore's ecosystem turns ideas into products faster," notes an ExxonMobil exec. Academics highlight talent development: NTU professors report 30% research funding boost via labs. Government views it as ROI: every S$1 invested returns S$3-5 in GDP.

Challenges include talent competition and IP navigation, addressed via streamlined contracts and upskilling programs.

Economic and Societal Implications

These investments bolster Singapore's GDP (R&D contributes 2.2%+), create 20,000 high-tech jobs by 2030, and spur spin-offs like 50+ startups from Corp Labs. Societally, innovations in health (e.g., cancer diagnostics) and sustainability enhance quality of life. For higher ed, it means more funded projects, attracting global talent to NUS/NTU.

Photo by Joshua Gresham on Unsplash

Future Outlook: Scaling Up for RIE2030

With RIE2030 allocating S$25 billion, A*STAR targets S$5B+ in new industry funds. Priorities: AI manufacturing, precision medicine, green tech. New institutes like the National Artificial and Intelligent Technologies Institute (NAITI) will amplify PPPs. For researchers, opportunities abound in postdoc roles, industry attachments.

Actionable Insights for Researchers and Academics

• Apply to A*STAR scholarships for PhD/postdoc (via universities).
• Explore Corp Lab attachments for industry exposure.
• Leverage joint grants with MNCs for collaborative projects.
• Monitor NRF calls for PPP funding opportunities.

Singapore's model offers a blueprint: collaborative R&D as economic engine. As A*STAR surpasses S$1.1B, expect bolder innovations shaping tomorrow.